Patient Guide: A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 20 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06827236
Status: 🟢 Enrolling Now
Condition: Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 20 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Beverly Hills, California
  • • Port Saint Lucie, Florida
  • • Atlanta, Georgia
  • • And 17 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer - Join Clinical Trial NCTNCT06827236

How to Join This Clinical Trial - NCTNCT06827236

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06827236 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 20 locations. Find a study site near you:

Clinical Research Site

Beverly Hills, California 90211 - United States

Status: RECRUITING

Clinical Research Site

Port Saint Lucie, Florida 34952 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: RECRUITING

Clinical Research Site

Grand Rapids, Michigan 49546 - United States

Status: RECRUITING

Clinical Research Site

Kansas City, Missouri 64111 - United States

Status: RECRUITING

Clinical Research Site

Florham Park, New Jersey 07932 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10065 - United States

Status: RECRUITING

Clinical Research Site

San Antonio, Texas 78229 - United States

Status: RECRUITING

Clinical Research Site

Bengbu, 233004 - China

Status: RECRUITING

Clinical Research Site

Changchun, 130000 - China

Status: RECRUITING

And 10 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation